Type III Hyperlipoproteinemia: A Focus on Lipoprotein Receptor-Apolipoprotein E2 Interactions
- 1 January 1986
- book chapter
- Published by Springer Nature
- Vol. 201, 273-288
- https://doi.org/10.1007/978-1-4684-1262-8_24
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology.Circulation, 1985
- Lipoproteins of Special Significance in AtherosclerosisAnnals of the New York Academy of Sciences, 1985
- The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNACell, 1984
- New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.JCI Insight, 1984
- Lipoprotein receptors and cholesterol homeostasisBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1983
- Identical Structural and Receptor Binding Defects in Apolipoprotein E2 in Hypo-, Normo-, and Hypercholesterolemic DysbetalipoproteinemiaJCI Insight, 1983
- Regulation of Hepatic Lipoprotein Receptors in the Dog. RAPID REGULATION OF APOLIPOPROTEIN B,E RECEPTORS, BUT NOT OF APOLIPOPROTEIN E RECEPTORS, BY INTESTINAL LIPOPROTEINS AND BILE ACIDSJCI Insight, 1983
- Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modificationBiochemistry, 1981
- Polymorphism of apolipoprotein EClinical Genetics, 1979
- Inhibition of the binding of low‐density lipoprotein to its cell surface receptor in human fibroblasts by positively charged proteinsJournal of Supramolecular Structure, 1978